Abstract: A liquid capsule of cannabis, ginseng, and turmeric rhizome oil blend consisting essentially of an oil blend of cannabis oil, turmeric rhizome oil, and ginseng oil in a liquid capsule. There is less than 4 ppm of tetrahydrocannabinol (THC) in the oil blend.
Abstract: Methods of converting CBD to ?8-THC to ?10-THC to ?6a10a-THC are described and the products disclosed. Various adjustments can be made to the reactions resulting in increased or decreased product and by-product.
Type:
Grant
Filed:
August 26, 2021
Date of Patent:
October 31, 2023
Inventors:
Alexander William Siegel, Alek Enrique Valle, Devin Jay Wall
Abstract: The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
Type:
Application
Filed:
July 15, 2016
Publication date:
March 21, 2019
Inventors:
Raphael Mechoulam, Flavio Pereira Kapczinski, Jose Alexandre De Souza Crippa, Antonio Waldo Zuardi, Jaime Eduardo Cecilio Hallak, Francisco Silveira Guimaraes, Aviva Breuer
Abstract: A barricade light is retrofitted to receive a light emitting diode circuit. The circuit includes both a pulse activated switch and light sensitive switch for operation.
Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
Type:
Application
Filed:
July 2, 2015
Publication date:
January 7, 2016
Inventors:
Michael J. Mona, III, Joshua A. Hartsel, Greg Waterbury
Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
Type:
Application
Filed:
January 4, 2021
Publication date:
December 23, 2021
Inventors:
Michael J. Mona, III, Joshua A. Hartsel, Greg Waterbury
Abstract: Systems and methods for extracting a compound of interest from plant material, such as acannabidiol (CBD) from cannabis, are provided. Particularly, the disclosed systems and methods utilize a crude oil to separate water, fats, and proteins prior to preparation of a CBD distillate. The systems and methods are operable with conventional solvents containing between about 5 wt % and about 8 wt % water.
Abstract: The present invention provides compositions and methods for the treatment of skin lesions. In particular, embodiments of the invention provide topical compositions useful in the treatment and alleviation of cutaneous symptoms associated with psoriasis, dermatitis and other dermatological conditions including ulcers or lesions, wherein the compositions contain CBD oil.
Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
Type:
Application
Filed:
April 28, 2016
Publication date:
January 26, 2017
Inventors:
Michael J. Mona, III, Joshua A. Hartsel, Greg Waterbury
Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
Type:
Application
Filed:
July 15, 2019
Publication date:
November 21, 2019
Inventors:
Michael J. Mona, III, Joshua A. Hartsel, Greg Waterbury
Abstract: A cannabis conversion method includes providing a starting material that includes cannabidiol (CBD), combining the starting material with a solvent and a Lewis acid to form a mixture, the solvent and the Lewis acid reacting with the CBD to form a product Delta-8-tetrahydrocannabinol in the mixture, and removing the solvent and the Lewis acid from the mixture, the removing leaving the product Delta-8-tetrahydrocannabinol.
Abstract: The present invention relates to an oral care composition comprising a Cellulose Binding Domain and further ingredient conventionally used in oral care compositions, oral care products, and the use of CBDs for oral care purposes.
Abstract: A product comprising theanine, caffeine, and CBD is disclosed. Alternatives to the specific components are also described. A product comprising theanine, pyridoxine triacetate, and CBD is also disclosed. Alternatives to the specific components are also described. In an embodiment, an oral thin film strip delivery system includes a polymer, muco-adhesive, or other component that allows the product to dissolve in the mouth.
Abstract: The present disclosure relates to the new compounds and improved treatment regimens that are effective in treating patients and minimizing the negative side effects previously associated with pulmonary care and treatment. Specifically, liposomal cannabinoids with or without other known treatments are used to provide a more effective and safer treatment for Asthma and/or pulmonary inflammation disorders or conditions in a diverse population.
Abstract: Disclosed is a chimeric polypeptide for use in-vitro tissue engineering, the polypeptide including cellulose binding domain (CBD), a cell effector protein (CEP), and a linker linking the CBD to the CEP, as well as systems and method utilizing same.
Type:
Application
Filed:
August 19, 2021
Publication date:
September 28, 2023
Inventors:
Oded Shoseyov, Amit Yaari, Tzvi Zvirin, Shiri Baran Elmedvi, Efrat Avigad Laron, Yonatan Eran
Abstract: The present invention discloses a hemp plant variety designated NBS CBD-1. The cultivar is a feminized, autoflowering, high CBD hemp variety. The plant and products thereof can be useful for a variety of medicinal uses, including movement disorders, anxiety, and pain, as well as a variety of industrial uses. Also provided are tissues cultures, seeds, and plant cells of the NBS CBD-1 variety.
Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
Type:
Grant
Filed:
July 2, 2015
Date of Patent:
May 17, 2016
Assignee:
CV SCIENCES, INC.
Inventors:
Michael J. Mona, III, Joshua A. Hartsel, Greg Waterbury
Abstract: The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.
Type:
Application
Filed:
September 10, 2021
Publication date:
March 3, 2022
Inventors:
Colin STOTT, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
Abstract: Herein are described apparatus and processes for the preparation of cannabinoids, such as cannabidiol (CBD) and derivatives thereof. The apparatus and processes described can be used for the one-step, flow-mediated synthesis of cannabidiol and derivatives with improved overall yield, material throughput, and product purity relative to batch processes.
Type:
Application
Filed:
April 14, 2020
Publication date:
October 15, 2020
Applicant:
TRUSTEES OF BOSTON UNIVERSITY
Inventors:
John A. PORCO, Aaron B. BEELER, Lauren E. BROWN, Richard V. TRILLES
Abstract: The present invention relates to compositions and methods for over-expressing pectin methylesterases (PMEs), particularly type 1 PMEs (PME1s), in plants while maintaining growth as compated to the wild type. The plants of the invention have improved properties compared to the wild type, particularly improved resistance to salinity.
Type:
Application
Filed:
March 26, 2008
Publication date:
August 19, 2010
Applicants:
CBD Technologies Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem